Skip to main content
BrainCited

Folate per Nutritional Deficiency Cognitive Impairment

B

Critical for homocysteine metabolism and SAM production essential for neurotransmitter synthesis. MTHFR polymorphism carriers may benefit more from methylated forms (5-MTHF).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dfolate\u0026condition\u003Dnutritional\u002Ddeficiency\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Critical for homocysteine metabolism and SAM production essential for neurotransmitter synthesis. MTHFR polymorphism carriers may benefit more from methylated forms (5-MTHF).

Key Study Findings

Observational Study n=2582
Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the …
Dose: None vs: None Outcome: Cognitive impairment risk Effetto: OR=0.695 (Vit D); OR=0.777 (FA) p=0.003 (Vit D); p=0.034 (FA)

Popolazione: Elderly participants aged 60+ from NHANES 2011-2014

Cross-Sectional Study n=1966
Folate mediates cognitive impairment of aged people with periodontitis.
Dose: None vs: Placebo Effetto: Mediation proportion: dietary supplement folate 8.4%; serum total folate 9.1%; RBC folate 9.1% None
Review
B-vitamins and one-carbon metabolism during pregnancy: health impacts and challenges.
Dose: None vs: None Outcome: Pregnancy outcomes and offspring neurodevelopment Effetto: None None

Popolazione: Pregnant women (review)

Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None vs: Standard care or placebo Outcome: Global cognition in stroke survivors Effetto: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins) 0.009 (protein); 0.02 (B-vit)

Popolazione: Adult stroke survivors (20 trials + 14 observational)

Other
Fresh Genetic Insights Into Micronutrients Influences on Restless Legs Syndrome Risk.
Dose: None vs: None Outcome: Causal association of micronutrients with RLS Effetto: Retinol OR 0.46; Mg OR 0.62 None

Popolazione: European ancestry (7248 RLS cases, 19802 controls)

Randomized Controlled Trial Double-blind
Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.
Dose: Vitamin B12 (measured, not supplemented) vs: Within-trial comparison Outcome: B12/homocysteine association with PD outcomes Effetto: None None

Popolazione: Early Parkinson's disease patients

Key Statistics

10

Studi

1500

Partecipanti

Positive

B

Grado

Referenced Papers

Food and nutrition … 2024 19 citazioni
The Senior care … 2021 2 citazioni
Journal of Alzheimer's … 2018 281 citazioni
European journal of … 2012 225 citazioni
Evidence report/technology assessment 2006
The Cochrane database … 2003 263 citazioni
Current opinion in … 1998 30 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
400 mcg DFE/day (RDA)
cognitivesupport:
400-800 mcg/day

Limite massimo: 1,000 mcg/day from supplements (may mask B12 deficiency)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive 2582
None -- Positive 1966
None -- Positive --
None -- Mixed --
None -- Mixed --
Vitamin B12 (measured, not supplemented) -- Positive --
None -- Positive --
>5 mg/day -- Negative --

Momento migliore per l'assunzione: With or without food; morning preferred

Safety & Side Effects

Effetti collaterali segnalati

  • Generally well-tolerated
  • May mask B12 deficiency symptoms
  • Rare: insomnia or irritability at high doses

Interazioni note

  • Methotrexate (antagonist — folate reduces efficacy)
  • Anticonvulsants (phenytoin, carbamazepine — mutual interference)
  • Sulfasalazine (reduces folate absorption)

Livello di assunzione massimo tollerabile: 1,000 mcg/day from supplements (may mask B12 deficiency)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Folate help with Nutritional Deficiency Cognitive Impairment?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that Folate may support Nutritional Deficiency Cognitive Impairment management. Our evidence grade is B (Good Evidence).
How much Folate should I take for Nutritional Deficiency Cognitive Impairment?
Studies have used various dosages. A commonly studied range is 400 mcg DFE/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Folate?
Reported side effects may include Generally well-tolerated, May mask B12 deficiency symptoms, Rare: insomnia or irritability at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Folate and Nutritional Deficiency Cognitive Impairment?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Nutritional Deficiency Cognitive Impairment

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.